ImmunityBio Inc

+0.22 (+2.36%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.74B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.03 Million
Adjusted EPS-$0.20
See more estimates
10-Day MA$10.05
50-Day MA$10.97
200-Day MA$17.48
See more pivots

ImmunityBio Inc Stock, NASDAQ:IBRX

9920 Jefferson Boulevard, Culver City, California 90232
United States of America
Phone: +1.844.696.5235
Number of Employees: 171


ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in Culver City, CA.